1. Home
  2. OTEX vs ASND Comparison

OTEX vs ASND Comparison

Compare OTEX & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Open Text Corporation

OTEX

Open Text Corporation

N/A

Current Price

$23.70

Market Cap

6.2B

Sector

Technology

ML Signal

N/A

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

N/A

Current Price

$271.29

Market Cap

17.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OTEX
ASND
Founded
1991
2006
Country
Canada
Denmark
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
17.1B
IPO Year
1998
2014

Fundamental Metrics

Financial Performance
Metric
OTEX
ASND
Price
$23.70
$271.29
Analyst Decision
Hold
Strong Buy
Analyst Count
12
21
Target Price
$28.14
★ $315.14
AVG Volume (30 Days)
★ 1.2M
591.6K
Earning Date
11-05-2026
11-12-2026
Dividend Yield
★ 4.69%
N/A
EPS Growth
★ 56.36
N/A
EPS
★ 0.64
N/A
Revenue
★ $2,815,241,000.00
N/A
Revenue This Year
N/A
$91.55
Revenue Next Year
$1.67
$46.52
P/E Ratio
$37.28
★ N/A
Revenue Growth
★ 22.88
N/A
52 Week Low
$19.78
$188.08
52 Week High
$34.10
$282.15

Technical Indicators

Market Signals
Indicator
OTEX
ASND
Relative Strength Index (RSI) 36.22 66.66
Support Level $23.38 $214.93
Resistance Level $23.71 $272.47
Average True Range (ATR) 0.66 7.53
MACD -0.34 1.57
Stochastic Oscillator 2.74 70.63

Price Performance

Historical Comparison
OTEX
ASND

About OTEX Open Text Corporation

Open Text Corp provides data management for enterprise AI, offering a secure data foundation and trusted context for credible AI outcomes across private, public, and sovereign cloud, managed cloud services, API, and on-premises environments. The Company also provides cybersecurity solutions to protect sensitive data, applications and systems across complex hybrid environments, including identity and access management, threat detection and response, data protection and application security. It serves private, public, and regulated sectors, including retail, financial services, government, manufacturing, healthcare, energy, and logistics, with clients. Geographically, it derives maximum revenue from the Americas.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

Share on Social Networks: